HP's New CFO: A Leap from Medtronic to Tech Giant

Minneapolis, USAMon Oct 07 2024
Advertisement
HP has appointed Karen Parkhill as its new Chief Financial Officer (CFO), effective August 5. Parkhill is leaving her post at Medtronic, a global medical devices company, where she has been the Executive Vice President and CFO since 2016. This move highlights the trend of top finance chiefs switching industries to bring fresh perspectives. Parkhill's extensive experience in finance and leadership makes her a valuable addition to HP. Medtronic, known for products like cardiac devices and insulin pumps, has seen some executive turnover recently. The company announced that Parkhill will continue in her role until August 2 while they search for her replacement. This transition shows that companies value financial expertise and leadership skills above all else in their CFOs.
HP's CEO, Enrique Lores, welcomed Parkhill, stating that her experience and expertise will drive the company's growth. Parkhill expressed her excitement to join HP at a pivotal time for both the company and the industry. Her journey to becoming a CFO was non-traditional; she started at JPMorgan in investment banking and worked her way up. Parkhill's love for math and business led her to finance. She noticed that investment banking was one of the most coveted jobs after college. Her willingness to take on new challenges has defined her career. At HP, she will succeed Marie Myers, who stepped down to join Hewlett Packard Enterprise. Parkhill's compensation package at HP includes an annual base salary of $950,000 and a cash bonus of 135% of her base salary. She will also receive a cash signing bonus of $1. 5 million, half payable on her six-month anniversary and the other half on her one-year anniversary. This development comes amidst an increasing trend of mergers and acquisitions (M&A), with deal values reaching $535 billion in the first five months of 2024, a nearly 30% increase from the previous year.
https://localnews.ai/article/hps-new-cfo-a-leap-from-medtronic-to-tech-giant-4c7f20e

actions